SXTPW · Insider Trading
60 Degrees Pharmaceuticals, Inc. Warrant
Every open-market purchase and sale reported by SXTPW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Geoffrey S Dow | President and CEO | Buy | +7,350 | +$10.13K |
| 2025-12-16 | Geoffrey S Dow | President and CEO | Buy | +9,670 | +$7.76K |
| 2025-12-12 | Geoffrey S Dow | President and CEO | Buy | +12,963 | +$12.20K |
| 2025-09-15 | Geoffrey S Dow | President and CEO | A | +7,201 | +$10.00K |
| 2025-08-14 | Kristen Landon | Chief Operating Officer | A | +4,540 | — |
| 2025-08-14 | Kristen Landon | Chief Operating Officer | A | +4,167 deriv. | — |
| 2025-06-09 | Geoffrey S Dow | President and CEO | A | +4,376 | +$13.06K |
| 2025-06-05 | Cheryl Xu | Director | Buy | +5,000 | +$14.41K |
| 2025-01-24 | Geoffrey S Dow | President and CEO | A | +525,000 deriv. | — |
| 2025-01-24 | Tyrone Miller | CFO | A | +75,000 deriv. | — |
| 2025-01-21 | Geoffrey S Dow | President and CEO | A | +14,394 | — |
| 2025-01-21 | Tyrone Miller | CFO | A | +11,626 | — |
| 2024-12-18 | Cheryl Xu | Director | Buy | +13,000 | +$21.40K |
| 2024-12-09 | Geoffrey S Dow | President and CEO | Buy | +73,951 | +$89.76K |
| 2024-11-21 | Geoffrey S Dow | President and CEO | Buy | +7,000 | +$6.37K |
| 2024-09-11 | Cheryl Xu | Director | Buy | +5,000 | +$8.50K |
| 2024-05-21 | Stephen Toovey | Director | A | +4,000 | +$892 |
| 2024-05-21 | Geoffrey S Dow | President and CEO | M | +85,000 | +$21.93K |
| 2024-05-21 | Charles W Allen | Director | M | +4,000 | +$892 |
| 2024-05-21 | Paul Field | Director | M | +4,000 | +$892 |
| 2024-05-21 | Cheryl Xu | Director | M | +2,000 | +$446 |
| 2024-05-21 | Tyrone Miller | CFO | A | +75,000 | +$19.35K |
| 2024-04-03 | Therapeutics International Sa Knight | — | C | +43,398 | +$216.18K |
| 2024-02-02 | Geoffrey S Dow | President and CEO | Buy | +25,974 | +$9.74K |
| 2024-02-02 | Cheryl Xu | Director | MIXED | +202,000 | +$75.00K |
| 2023-07-12 | Tyrone Miller | Chief Financial Officer | A | +240,000 deriv. | — |
| 2023-07-12 | Geoffrey S Dow | President and CEO | A | +300,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Geoffrey S Dow | President and CEO | 35,250 | $927 |
| Tyrone Miller | CFO | 26,370 | $694 |
| Cheryl Xu | Director | 15,816 | $416 |
| Kristen Landon | Chief Operating Officer | 4,540 | $119 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SXTPW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.